Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sanil Bhatia

Showing results (21-30 of 54) with videos related to

Pageof 6
Sort By:
Journal of Medicinal Chemistry|November 9, 2022
Development of Fluorinated Peptoid-Based Histone Deacetylase (HDAC) Inhibitors for Therapy-Resistant Acute LeukemiaNina Reßing, Julian Schliehe-Diecks, Paris R Watson, et al.
Heliyon|July 29, 2024
Synergistic drug interactions of the histone deacetylase inhibitor givinostat (ITF2357) in CRLF2-rearranged pediatric B-cell precursor acute lymphoblastic leukemia identified by high-throughput drug screeningAthanasios Oikonomou, Titus Watrin, Luigia Valsecchi, et al.
Journal of Medicinal Chemistry|September 28, 2021
4-Acyl Pyrrole Capped HDAC Inhibitors: A New Scaffold for Hybrid Inhibitors of BET Proteins and Histone Deacetylases as Antileukemia Drug LeadsLinda Schäker-Hübner, Robin Warstat, Heinz Ahlert, et al.
Haematologica|August 11, 2018
The homeobox transcription factor HB9 induces senescence and blocks differentiation in hematopoietic stem and progenitor cellsDeborah Ingenhag, Sven Reister, Franziska Auer, et al.
Viruses|April 30, 2021
Deep Transfer Learning Approach for Automatic Recognition of Drug Toxicity and Inhibition of SARS-CoV-2Julia Werner, Raphael M Kronberg, Pawel Stachura, et al.
Journal of Medicinal Chemistry|December 6, 2022
Solid-Phase Synthesis of Cereblon-Recruiting Selective Histone Deacetylase 6 Degraders (HDAC6 PROTACs) with Antileukemic ActivityLaura Sinatra, Jing Yang, Julian Schliehe-Diecks, et al.
Journal of Medicinal Chemistry|January 2, 2026
Discovery of Histone Deacetylase 8-Specific Proteolysis-Targeting Chimeras with Anticancer Activity against Hematological MalignanciesShiyang Zhai, Marie Kemkes, Cindy-Esther Kponomaizoun, et al.
Phytochemistry|February 10, 2022
Prenylated cyclohexene-type meroterpenoids and sulfur-containing xanthones produced by Pseudopestalotiopsis theaeSergi Herve Akone, Hao Wang, Eitel Ngoh Misse Mouelle, et al.
Cell Death Discovery|June 11, 2024
Novel meriolin derivatives potently inhibit cell cycle progression and transcription in leukemia and lymphoma cells via inhibition of cyclin-dependent kinases (CDKs)Laura Schmitt, Julia Hoppe, Pablo Cea-Medina, et al.
Molecular Cancer|August 15, 2023
Unleashing T cell anti-tumor immunity: new potential for 5-Nonloxytryptamine as an agent mediating MHC-I upregulation in tumorsPaweł Stachura, Wei Liu, Haifeng C Xu, et al.
Pageof 6

Showing results (21-30 of 54) with videos related to

Sort By:
Pageof 6
Journal of Medicinal Chemistry|November 9, 2022
Development of Fluorinated Peptoid-Based Histone Deacetylase (HDAC) Inhibitors for Therapy-Resistant Acute LeukemiaNina Reßing, Julian Schliehe-Diecks, Paris R Watson, et al.
Heliyon|July 29, 2024
Synergistic drug interactions of the histone deacetylase inhibitor givinostat (ITF2357) in CRLF2-rearranged pediatric B-cell precursor acute lymphoblastic leukemia identified by high-throughput drug screeningAthanasios Oikonomou, Titus Watrin, Luigia Valsecchi, et al.
Journal of Medicinal Chemistry|September 28, 2021
4-Acyl Pyrrole Capped HDAC Inhibitors: A New Scaffold for Hybrid Inhibitors of BET Proteins and Histone Deacetylases as Antileukemia Drug LeadsLinda Schäker-Hübner, Robin Warstat, Heinz Ahlert, et al.
Haematologica|August 11, 2018
The homeobox transcription factor HB9 induces senescence and blocks differentiation in hematopoietic stem and progenitor cellsDeborah Ingenhag, Sven Reister, Franziska Auer, et al.
Viruses|April 30, 2021
Deep Transfer Learning Approach for Automatic Recognition of Drug Toxicity and Inhibition of SARS-CoV-2Julia Werner, Raphael M Kronberg, Pawel Stachura, et al.
Journal of Medicinal Chemistry|December 6, 2022
Solid-Phase Synthesis of Cereblon-Recruiting Selective Histone Deacetylase 6 Degraders (HDAC6 PROTACs) with Antileukemic ActivityLaura Sinatra, Jing Yang, Julian Schliehe-Diecks, et al.
Journal of Medicinal Chemistry|January 2, 2026
Discovery of Histone Deacetylase 8-Specific Proteolysis-Targeting Chimeras with Anticancer Activity against Hematological MalignanciesShiyang Zhai, Marie Kemkes, Cindy-Esther Kponomaizoun, et al.
Phytochemistry|February 10, 2022
Prenylated cyclohexene-type meroterpenoids and sulfur-containing xanthones produced by Pseudopestalotiopsis theaeSergi Herve Akone, Hao Wang, Eitel Ngoh Misse Mouelle, et al.
Cell Death Discovery|June 11, 2024
Novel meriolin derivatives potently inhibit cell cycle progression and transcription in leukemia and lymphoma cells via inhibition of cyclin-dependent kinases (CDKs)Laura Schmitt, Julia Hoppe, Pablo Cea-Medina, et al.
Molecular Cancer|August 15, 2023
Unleashing T cell anti-tumor immunity: new potential for 5-Nonloxytryptamine as an agent mediating MHC-I upregulation in tumorsPaweł Stachura, Wei Liu, Haifeng C Xu, et al.
Pageof 6